Prevention of seronegative rheumatoid arthritis: an entity of its own
- PMID: 39303732
- DOI: 10.1016/S2665-9913(24)00226-1
Prevention of seronegative rheumatoid arthritis: an entity of its own
Conflict of interest statement
SB received honoraria for lectures from AbbVie; Novartis; University of California, Berkeley; and Fresenius Kabi. GS received honoraria for lectures from Janssen, Novartis, Kyverna, and Cabaletta.
LinkOut - more resources
Full Text Sources